Advancements in cellular therapies, biomaterials, and gene-editing tools are transforming how the body’s own repair mechanisms are harnessed. By integrating cutting-edge approaches like CRISPR, stem cell transplantation, and scaffold-based tissue repair, scientists are closing the gap between damage and recovery. Within this dynamic field, regenerative medicine continues to evolve as a solution to chronic diseases and organ failure, replacing traditional methods that focus solely on symptom management. Researchers are now exploring how biological cues and microenvironment modulation can guide tissue regrowth more effectively. Clinical pipelines are expanding rapidly with new trials targeting cartilage regeneration, myocardial repair, and even neural tissue restoration. The potential of regenerative medicine is no longer confined to theoretical constructs—it is being translated into viable therapies with measurable patient outcomes.
Title :
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title :
Marco Polettini, DVM, Italy
Title :
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Personalized and Precision Medicine PPM as a unique healthcare model via pathology related modeling biodesign inspired translational applications and clinical practice of the next step generation to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation